Latest News


Neuroscience and Pain Research

World-leading research in the spotlight

World-leading research in the spotlight

The Neuroscience and Pain Research Showcase provided a timely opportunity to demonstrate the breadth of expertise across this priority research area at the Kolling. Co-ordinated by Professors Paul Glare and Lisa Harvey, the online event attracted more than 250 people. A diverse range of presentations focused on the cutting-edge research targeting mitochondrial disease, psychiatric disord.....
Read more

Category: Neuroscience and Pain Research, Research Excellence, World-leading technology

Researchers tackle one of the nation’s biggest health challenges

Researchers tackle one of the nation’s biggest health challenges

Researchers from the Kolling Institute will support an important, Australia-wide project to address the inappropriate use of medications in residential aged care. The initiative, to be co-ordinated by Monash University’s Centre for Medicine Use and Safety, has been awarded $2 million through the Medical Research Future Fund. It will see pharmacists embedded in residential aged care.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

Researchers to improve diagnosis for genetic disorders

Researchers to improve diagnosis for genetic disorders

Kolling researchers will drive a large, national research project to improve diagnostic rates for those with mitochondrial diseases and broaden treatment pathways. A $3 million grant from the Medical Research Future Fund is being invested in the project, which will involve clinicians, researchers and diagnostic scientists from a host of organisations including the Kolling and the Murdoch.....
Read more

Category: Neuroscience and Pain Research, Research Excellence

Australian first study to alleviate pain for those with spinal cord injuries

Australian first study to alleviate pain for those with spinal cord injuries

Researchers from the Kolling Institute will partner with international and Australian experts to examine an innovative approach to nerve pain for those with spinal cord injuries. The ground breaking study has been awarded more than $1.78 million through the Federal Government’s Medical Research Future Fund. Professors Ashley Craig, James Middleton and Paul Glare from the Kolling wi.....
Read more

Category: Funding support, Neuroscience and Pain Research

Age and sex influence the adverse effects of multiple medications

Age and sex influence the adverse effects of multiple medications

There are calls for a carefully-considered, tailored approach to the prescription of multiple medicines with new research finding a person’s age and sex influence the impact of multiple medications. More than half of older Australians take five or more regular medications, with the higher number of medications directly linked to a higher chance of adverse reactions, like falls, confusion.....
Read more

Category: Neuroscience and Pain Research, New Treatment

Cancer expertise recognised

Cancer expertise recognised

The Kolling’s Dr Amanda Hudson will lead an exciting pilot study after being awarded an innovation grant by the Mark Hughes Foundation for brain cancer research. The Bill Walsh Lab scientist is one of a select group to have received funding from the foundation. Her research will now investigate the early detection of disease progression in brain cancer. Dr Hudson said identifying changes.....
Read more

Category: Funding support, Neuroscience and Pain Research

Philanthropic funding brings new hope to those with chronic pain

Philanthropic funding brings new hope to those with chronic pain

Some of the nation’s leading pain experts are set to embark on research which they believe will change the way chronic pain is managed. The program of research will be carried out by the team from the Pain Management Research Institute after generous funding from the Ernest Heine Family Foundation. Located within the Kolling Institute and Royal North Shore Hospital, the Pain Management R.....
Read more

Category: Funding support, Neuroscience and Pain Research, New Treatment

Key appointment for Kolling researcher

Key appointment for Kolling researcher

Congratulations to the Kolling’s Dr Ryan Davis following his appointment as president-elect of the Australian Society for Medical Research. (ASMR) Dr Davis is part of the Neurogenetics team, driving research into mitochondrial diseases and Parkinson’s disease. His work bridges basic and clinical research, while he also supports the Neurogenetics Clinic at Royal North Shore Hospital to im.....
Read more

Category: Neuroscience and Pain Research